Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 42Colonic Neoplasms 14Rectal Neoplasms 13Neoplasms 12Neoplasm Metastasis 12Head and Neck Neoplasms 6Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Carcinoma, Squamous Cell 4Breast Neoplasms 4Recurrence 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Adenocarcinoma Of Esophagus 3Triple Negative Breast Neoplasms 2Gastrointestinal Neoplasms 2Cholangiocarcinoma 2Carcinoma 2Biliary Tract Neoplasms 2Urinary Bladder Neoplasms 1Solid Tumors 1Ovarian Neoplasms 1Inflammatory Breast Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Exanthema 1

Interventions

Paclitaxel 96Carboplatin 81Bevacizumab 62Gemcitabine 36liposomal doxorubicin 32pembrolizumab 30Topotecan 26olaparib 23Taxes 23niraparib 17Immunoglobulin G 17Disulfides 17Docetaxel 16Cyclophosphamide 16Cisplatin 14Nivolumab 11rucaparib 10durvalumab 10Doxorubicin 9Albumin-Bound Paclitaxel 8sargramostim 7pazopanib 7fludarabine phosphate 7fludarabine 7avelumab 7Magnetic Resonance Spectroscopy 7Ifosfamide 7epacadostat 6Trabectedin 6Sorafenib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ovarian Neoplasms × Panitumumab × Clear all
NCT01296035 2015-08-25

PanGem

Women and Infants Hospital of Rhode Island

Phase 2 Terminated
8 enrolled 6 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡